Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate

Urological Research

Volumn 32, Issue 1, 2004, Pages 36-40

  Kumar, Rajeev ^a   Kumar, Mahesh ^a   Jagannathan, N R ^a   Gupta, Narmada P ^a   Hemal, Ashok K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemical shift imaging; Gleason score; Malignancy; Nuclear magnetic resonance; PSA

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE;

ADULT; AGED; ARTICLE; BODY COIL; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTON NUCLEAR MAGNETIC RESONANCE; RELIABILITY; SCORING SYSTEM; SIGNAL DETECTION; SIGNAL NOISE RATIO; SPINE; VOLUNTEER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHOLINE; CITRIC ACID; CREATINE; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTONS;

EID: 1542378188     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-003-0372-8     Document Type: Article

References (22)

1. Yu KK, Hricak H (2000) Imaging prostate carcinoma. Radiol Clin North Am 38:59-85
2. Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H (2000) The prostate: MR imaging and spectroscopy. Radiol Clin North Am 38:115-138
3. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400-404
4. Schnall MD, Imai Y, Tomaszewski J, Pollack HM, Lenkinski RE, Kressel HY (1991) Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 78:797-802
5. Kurhanewicz J, Thomas A, Jajodia P, Weiner MW, James TL, Vigneron DB, Narayan P (1991) 31P spectroscopy of the human prostate gland in vivo using a transrectal probe. Magn Reson Med 22:404-413
6. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213:473-480
7. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P (1995) Citrate as an in-vivo marker to discriminate prostatic cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45(3):459-466
8. 3) spatial resolution. Radiology 198:795-805
9. DiBiase SJ, Hosseinzadeh K, Gullapalli RP, Jacobs SC, Naslund MJ, Sklar GN, Alexander RB, Yu C (2002) Magnetic Resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 52:429-438
10. Carter HB, Partin AW (1998) Diagnosis and staging of prostate cancer. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell's urology, 7th edn. WB Saunders Company, Philadelphia, vol. III, pp. 2519-2537
11. Costello LC, Franklin RB (1991) Concepts of citrate production and secretion by prostate. 1. Metabolic relationships. Prostate 18:25-46
12. Costello LC, Franklin RB (1991) Concepts of citrate production and secretion by prostate. 2. Hormonal relationships in normal and neoplastic prostate. Prostate 19:181-205
13. Costello LC, Franklin RB (1981) Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. Enzyme 26:281-287
14. Halliday KR, Fenoglio-Preiser C, Sillerud LO (1988) Differentiation of human tumors from nonmalignant tissue by natural-abundance 13C NMR spectroscopy. Magn Reson Med 7:384-411
15. Kim JK, Kim DY, Lee YH, Sung NK, Chung DS, Kim OD, Kim KB (1998) In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localised proton magnetic resonance spectroscopy using external-body surface coil. Mag Res Imag 16:1281-1288
16. 1H MRS and MRI. Mag Res Imag 15:1177-1186
17. 1H magnetic resonance spectroscopy and biochemical study. Mag Res Med 29:149-157
18. Lowry M, Liney GP, Turnbull LW, Manton DJ, Blackband SJ, Horsman A (1996) Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy. Zonal and age-related differences. Magn Reson Med 36:352-358
19. Schick F, Bongers H, Kurz S, Jung WI, Pfeffer M, Lutz O (1993) Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T. Magn Reson Med 29:38-43
20. Heerschap A, Jager GJ, van der Graaf M, Barentsz JO, de la Rosette JJ, Oosterhof GO, Ruijter ET, Ruijs SH (1997) In vivo Proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 17:1455-1460
21. 1H MR spectroscopy of the normal and malignant human prostates in vivo. J Magn Reson 87:610-619
22. Kaji Y, Wada A, Imaoka I, Matsuo M, Terachi T, Kobashi Y, Sugimura K, Faujii M, Maruyama K, Takizawa O (2002) Proton two-dimentional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil. J Magn Reson Imaging 16:697-706